Results 81 to 90 of about 27,400 (229)

Anti-Müllerian Hormone Is a Marker of Gonadotoxicity in Pre- and Postpubertal Girls Treated for Cancer:A Prospective Study [PDF]

open access: yes, 2012
Context: Cytotoxic treatment may accelerate depletion of the primordial follicle pool, leading to impaired fertility and premature menopause. Assessment of ovarian damage in prepubertal girls is not currently possible, but Anti-Müllerian Hormone (AMH) is
Anderson, Richard A   +5 more
core   +1 more source

Anti-Mullerian hormone and endometrial cancer: a multi-cohort study [PDF]

open access: yesBritish Journal of Cancer, 2017
The Mullerian ducts are the embryological precursors of the female reproductive tract, including the uterus; anti-Mullerian hormone (AMH) has a key role in the regulation of foetal sexual differentiation. Anti-Mullerian hormone inhibits endometrial tumour growth in experimental models by stimulating apoptosis and cell cycle arrest.
Fortner, Renée T.   +26 more
openaire   +5 more sources

Psychogenic polydipsia in dogs – a review of pathogenesis, diagnosis and treatment

open access: yesJournal of Small Animal Practice, EarlyView.
Polyuria and polydipsia represent a common clinical presentation in dogs and may result from numerous disorders affecting different body systems. Compulsive water consumption is characteristic of psychogenic polydipsia, a primary polydipsia disorder rooted in neurologic, behavioural or environmental factors.
G. Pavlovsky
wiley   +1 more source

The Effect of Vitamin D Supplementation on Serum Levels of Anti-Müllerian Hormone [PDF]

open access: yesMajallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul
Background and Objective: Anti-Müllerian hormone is used as an indicator of ovarian reserve in the diagnosis of infertility. Vitamin D regulates the serum levels of this hormone.
Z Panahi   +3 more
doaj  

Comparison between the levels of anti mullerian hormone after treatment with clomid versus letrozole in polycystic women: an experimental study

open access: yesJournal of the Pakistan Medical Association
Objective: To compare the effect of two ovulation induction drugs on anti-Mullerian hormone level in polycystic women. Method: The experimental cohort study was done at the infertility outpatient clinics of Al-Yarmouk Teaching Hospital, Baghdad, Iraq,
Manal Madany Abdel Qader   +2 more
doaj   +1 more source

Correlation between three assay systems for anti-Müllerian hormone (AMH) determination [PDF]

open access: yes, 2012
published_or_final_versio
Anderson, RA   +5 more
core  

Efficacy of Fertility‐Sparing Treatment With Progestin Is Associated With Different Molecular Classification in Endometrial Carcinoma and Atypical Endometrial Hyperplasia

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
Molecular profiles and outcomes of CR rate in 74 cases. ABSTRACT Objective To investigate the impact of various molecular characteristics on the outcomes of fertility‐preserving therapy in patients with endometrial cancer (EC) and atypical endometrial hyperplasia (AEH).
Xue‐Qian Qian   +4 more
wiley   +1 more source

Response of xenografts of developing human female reproductive tracts to the synthetic estrogen, diethylstilbestrol. [PDF]

open access: yes, 2017
Human female fetal reproductive tracts 9.5-22 weeks of gestation were grown for 1 month in ovariectomized athymic adult female mouse hosts that were either untreated or treated continuously with diethylstilbestrol (DES) via subcutaneous pellet.
Baskin, Laurence   +5 more
core   +2 more sources

Luteinizing hormone receptor knockout mouse: What has it taught us?

open access: yesAndrology, Volume 14, Issue 4, Page 1017-1028, May 2026.
Abstract Luteinizing hormone (LH), along with its agonist choriongonadotropin (hCG) in humans, is the key hormone responsible for the tropic regulation of the gonadal function. LH and hCG act through their cognate receptor, the luteinizing hormone/choriongonadotropin receptor (LHCGR; more appropriately LHR in rodents lacking CG), located in the testis ...
Ilpo T. Huhtaniemi
wiley   +1 more source

Women with PCOS have a later menopausal transition and a lower prevalence of menopausal symptoms at age 46: A population‐based birth cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 836-846, May 2026.
Findings from a population‐based cohort study indicate that late peri−/postmenopausal status, as well as menopausal symptoms, were less prevalent in women with PCOS at age 46, supporting the hypothesis of prolonged ovarian function and a delayed menopausal transition with this condition. Created in https://BioRender.com.
Johanna Lavi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy